Literature DB >> 21813722

Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years.

Yvonne Deleré1, Melanie Schuster, Elena Vartazarowa, Thomas Hänsel, Ingke Hagemann, Simone Borchardt, Heike Perlitz, Achim Schneider, Sabine Reiter, Andreas M Kaufmann.   

Abstract

Self-sampling by cervicovaginal lavage could be an attractive method to detect high-risk human papillomavirus (hr-HPV) infections to identify women with a risk of cervical precancer. The objective of our study was to use self-sampling for the first time in a cross-sectional approach to determine HPV prevalence and genotype distribution. We evaluated participants' acceptance and laboratory results from self-obtained samples versus endocervical brush samples obtained by gynecologists. To determine the sensitivity of both sampling methods in presumed high- and low-prevalence settings, two groups of women 20 to 30 years of age with (n = 55) and without (n = 101) a recent suspicious cytological smear were compared. Overall, 76% (95% confidence interval [95% CI], 65 to 88) of women with and 40% (95% CI, 30 to 49) of women without a recent suspicious cytological smear tested HPV positive. The prevalences of high-risk HPV strains were 71% (95% CI, 59 to 83) and 32% (95% CI, 22 to 41), respectively, for these two groups. The agreement for hr-HPV between the two sampling methods for women with and without suspicious cytology was 84% (κ = 0.65; 95% CI, 0.44 to 0.86) and 91% (κ = 0.78; 95% CI, 0.64 to 0.92), respectively. Participants rated the user-friendliness of the self-sampling method on a visual analog scale from 0 (easy) to 100 (difficult) with a median of 12. In conclusion, self-sampling by cervicovaginal lavage is a reliable method to determine hr-HPV prevalence and is well accepted by young adult females.

Entities:  

Mesh:

Year:  2011        PMID: 21813722      PMCID: PMC3187348          DOI: 10.1128/JCM.01026-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening.

Authors:  Heidi E Jones; Maarten A H M Wiegerinck; Theodoor E Nieboer; Ben W Mol; Carolyn L Westhoff
Journal:  Sex Transm Dis       Date:  2008-11       Impact factor: 2.830

2.  Screening for cervical neoplasia by self-assessment for human papillomavirus DNA.

Authors:  P Hillemanns; R Kimmig; U Hüttemann; C Dannecker; C J Thaler
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; L H Jaspars; F J Voorhorst; R H M Verheijen; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

5.  HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.

Authors:  Murat Gök; Daniëlle A M Heideman; Folkert J van Kemenade; Johannes Berkhof; Lawrence Rozendaal; Johan W M Spruyt; Feja Voorhorst; Jeroen A M Beliën; Milena Babovic; Peter J F Snijders; Chris J L M Meijer
Journal:  BMJ       Date:  2010-03-11

6.  Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.

Authors:  Markus Schmitt; Bolormaa Dondog; Tim Waterboer; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

7.  Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial.

Authors:  H E Jones; L Altini; A de Kock; T Young; J H H M van de Wijgert
Journal:  Sex Transm Infect       Date:  2007-09-27       Impact factor: 3.519

8.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

9.  HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.

Authors:  A Szarewski; L Cadman; D Mesher; J Austin; L Ashdown-Barr; R Edwards; D Lyons; J Walker; J Christison; A Frater; J Waller
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

10.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors:  G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  15 in total

1.  Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix Cytology.

Authors:  Z Hilal; C Tempfer; S Schiermeier; J Reinecke; C Ruppenkamp; Z Hilal
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

2.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Authors:  Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

Review 3.  Adolescent human papillomavirus vaccination in the United States: Opportunities for integrating pharmacies into the immunization neighborhood.

Authors:  Joseph P Fava; Jacob Colleran; Francesca Bignasci; Raymond Cha; Paul E Kilgore
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

4.  A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Authors:  David H Adler; Fatima Laher; Erica Lazarus; Katherine Grzesik; Glenda E Gray; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013-09-18

5.  High level of agreement between clinician-collected and self-collected samples for HPV detection among South African adolescents.

Authors:  D H Adler; A Almudevar; G E Gray; B Allan; A-L Williamson
Journal:  J Pediatr Adolesc Gynecol       Date:  2012-08       Impact factor: 1.814

6.  Acceptability of cervical and anal HPV self-sampling in a sample of Hispanic women in Puerto Rico.

Authors:  Ana P Ortiz; Natalia Alejandro; Cynthia M Pérez; Yomayra Otero; Marievelisse Soto-Salgado; Joel M Palefsky; Guillermo Tortolero-Luna; Josefina Romaguera
Journal:  P R Health Sci J       Date:  2012-12       Impact factor: 0.705

7.  Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.

Authors:  Barrett Sewali; Kolawole S Okuyemi; Asli Askhir; Jerome Belinson; Rachel I Vogel; Anne Joseph; Rahel G Ghebre
Journal:  Cancer Med       Date:  2015-02-04       Impact factor: 4.452

8.  Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.

Authors:  Cornelius Remschmidt; Michaela Fesenfeld; Andreas M Kaufmann; Yvonne Deleré
Journal:  BMC Public Health       Date:  2014-12-05       Impact factor: 3.295

9.  Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.

Authors:  Yvonne Deleré; Cornelius Remschmidt; Josefine Leuschner; Melanie Schuster; Michaela Fesenfeld; Achim Schneider; Ole Wichmann; Andreas M Kaufmann
Journal:  BMC Infect Dis       Date:  2014-02-19       Impact factor: 3.090

10.  Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2).

Authors:  Stefanie Castell; G Krause; M Schmitt; M Pawlita; Y Deleré; N Obi; D Flesch-Janys; Y Kemmling; A M Kaufmann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-11       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.